Dapinelat 30/60 30mg. 60mg Tablet
PDF Leaflet Revision Date: 29 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and prophylaxis of chronic stable angina pectoris.
Dosage (summary)
Initial dose: 30 mg once daily; max: 90 mg once daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Grapefruit juice
- Rifampicin
- Macrolide antibiotics
- Diltiazem
Contraindications
- Hypersensitivity to nifedipine
- Cardiogenic shock
- Aortic stenosis
- Myocardial infarction
- Gastrointestinal obstruction
Common side effects
- Headache
- Constipation
- Peripheral edema
- Dizziness
Counselling Points
- Swallow tablets whole
- Avoid grapefruit juice
- Monitor for hypotension
- Report any allergic reactions
Serious warnings
- Caution in hypotension
- Monitor blood pressure with IV magnesium sulfate
- Risk of obstructive symptoms
Important Disclaimer
The Dapinelat 30/60 30mg. 60mg Tablet professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
